Investment
Features
FeesSafety
Academy
More
Pluang+

Compare UBC Medical Indonesia Tbk. (LABS) vs Tirta Mahakam Resources Tbk (TIRT) Price & Performance

UBC Medical Indonesia Tbk.Trade
Tirta Mahakam Resources TbkTrade

Price performance (Past 24H)

Key statistics

UBC Medical Indonesia Tbk. vs Tirta Mahakam Resources Tbk — how do they compare? UBC Medical Indonesia Tbk. trades at Rp174 (market cap 691.25B, 635.5K 24h volume), while Tirta Mahakam Resources Tbk trades at Rp590 (market cap 657.65B, 520K 24h volume). The key difference: UBC Medical Indonesia Tbk. and Tirta Mahakam Resources Tbk are close in size by market cap, and UBC Medical Indonesia Tbk. is more actively traded (635.5K versus 520K). Which is the better fit depends on your goals.

LABSTIRT
Market Cap
691.25B657.65B
Volume
635.5K520K
Lot
6.36K5.2K
Turnover
110.15M
Average Price
173.33
Value
110.15M
Indicative Equilibrium Price
174
Indicative Equilibrium Volume
50

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

LABS
View details
TIRT
View details

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS

About Tirta Mahakam Resources Tbk

PT Tirta Mahakam Resources Tbk (The Company) was established based on Deed No. 245 dated April 22, 1981 jo. Revision deed No. 14 dated January 11, 1982, both of which were made in front of Notary Kartini Muljadi, SH. The Company started its commercial production in November 1983. The Companys domicilie is in South of Jakarta with its factories in Samarinda, East Kalimantan.

Read more on TIRT